Every year, an estimated half-million Americans undergo surgery to have a stent prop open a coronary artery narrowed by plaque. But sometimes the mesh tubes get clogged. Scientists report in the journal ACS Nano a new kind of multi-tasking stent that could minimize the risks associated with the procedure. It can sense blood flow and temperature, store and transmit the information for analysis and can be absorbed by the body after it finishes its job.
Leading scientists at the University of Sheffield have discovered nanotechnology could hold the key to preventing deep bone infections, after developing a treatment which prevents bacteria and other harmful microorganisms growing.
Nanosphere, Inc., a company enhancing medicine through targeted molecular diagnostics, today announced that 18 studies performed by various U.S. and international hospitals were recently presented at the annual Clinical Virology Symposium (CVS) in Daytona Beach, Florida, the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Copenhagen, Denmark, and the Making a Difference in Infectious Diseases (MAD-ID) Conference in Orlando, Florida.
We live in fear of 'superbugs': infectious bacteria that don't respond to treatment by antibiotics, and can turn a routine hospital stay into a nightmare. A 2015 Health Canada report estimates that superbugs have already cost Canadians $1 billion, and are a "serious and growing issue." Each year two million people in the U.S. contract antibiotic-resistant infections, and at least 23,000 people die as a direct result.
Cerulean Pharma Inc. today announced that the U.S. Food and Drug Administration, or FDA, has granted orphan drug designation to CRLX101 for the treatment of ovarian cancer.
Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company"), a clinical-stage biopharmaceutical company principally focused on the development of lipid-based prescription therapeutics for the treatment of infectious diseases, today announced that it will be presenting at the Fourth Annual SeeThru Equity Microcap Investor Conference being held May 28, 2015, at Convene Grand Central, New York, NY.
Biomedical researchers at Cedars-Sinai have invented a tiny drug-delivery system that can identify cancer cell types in the brain through “virtual biopsies” and then attack the molecular structure of the disease.
NanoMRI is a scanning technique that produces nondestructive, high-resolution 3-D images of nanoscale objects, and it promises to become a powerful tool for researchers and companies exploring the shape and function of biological materials such as viruses and cells in much the same way as clinical MRI today enables investigation of whole tissues in the human body.
Great excitement at Kiel University: As the DFG (German Research Foundation) announced today (Thursday, May 21), it will continue to support the research on molecules which function like machines with another 8.9 million EUR. This funding will allow the scientists in Germany's northernmost state to develop new engineering techniques for building tiny machine-like molecules over the next four years.
NIBIB-funded researchers have developed a highly sensitive and accurate imaging technique for non-invasive screening of lymph nodes for metastatic cancer. Current practice calls for invasive surgical biopsies to determine whether deadly metastatic cancer cells have invaded the lymph nodes.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.